Akut mieloid leukémia (AML): vizsgálatok itt: Norvégia
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleBleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
- Where
- Bergen, Oslo, Stavanger, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 875 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07223814 · EU 2025-522767-15-00 - 3. fázisTaking peoplePhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
- Where
- Bergen, Oslo, Stavanger, Tromso, Trondheim
- Életkor
- 18 év to 75 év
- People
- 650 worldwide
- Run by
- University of Ulm
See details and how to joinNCT04628026 · EU 2023-507518-28-00 - 3. fázisTaking peopleA study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia (AML) with a specific gene abnormality who have not previously been treated and who are not eligible for intensive chemotherapy.
- Where
- Bergen, Oslo, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
See details and how to join2024-512753-24-00 · EU 2024-512753-24-00 - 3. fázisTaking peopleCHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
- Where
- Bergen, Oslo, Tromsoe, Trondheim
- Életkor
- Up to 64 év
- People
- 675 worldwide
- Run by
- Prinses Maxima Centrum voor Kinderoncologie B.V.
See details and how to join2023-504999-25-00 · EU 2023-504999-25-00 - 2. fázisTaking people(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- Where
- Oslo
- Életkor
- 18 év and over
- People
- 140 worldwide
- Run by
- Cogent Biosciences, Inc.
See details and how to joinNCT04996875 · EU 2024-511407-42-00 - 3. fázisTaking peopleRevumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
- Where
- Bergen, Drammen, Loerenskog, Oslo, Stavanger, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 448 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT06652438 · EU 2024-512733-32-00 - 3. fázisTaking peopleIvosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy
- Where
- Bergen, Oslo, Tromsø, Trondheim
- Életkor
- 18 év and over
- People
- 227 worldwide
- Run by
- Stichting Hemato-Oncologie voor Volwassenen Nederland
See details and how to joinNCT07075016 - 2. fázisTaking peopleCHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
- Where
- Bergen, Oslo, Tromsoe, Trondheim
- Életkor
- 1 hónap to 18 év
- People
- 60 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06262438 · EU 2023-505000-27-01 - 1/2. fázisTaking peopleA Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients
- Where
- Bergen, Trondheim
- Életkor
- 18 év and over
- People
- 48
- Run by
- Haukeland University Hospital
See details and how to joinNCT06199557 · EU 2022-501992-15-00 - 3. fázisTaking peopleStudying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AML
- Where
- Oslo
- Életkor
- Up to 18 év
- People
- 170 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT05477589 - 3. fázisTaking peopleNOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years
- Where
- Bergen, Oslo, Tromsoe, Trondheim
- Életkor
- Up to 64 év
- People
- 730 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to joinNCT01828489 · EU 2024-518254-16-00 - 2. fázisTaking peopleAzacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling
- Where
- Bergen, Stavanger, Tromsoe, Trondheim
- Életkor
- 18 év and over
- People
- 117 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT05431257 · EU 2023-510415-19-00 - 2. fázisTaking peoplePrecision Therapy Versus Standard Therapy in AML and MDS in Elderly
- Where
- Lørenskog
- Életkor
- 60 év and over
- People
- 36
- Run by
- University Hospital, Akershus
See details and how to joinNCT05025098